Drug · DIN 02221985
RENEDIL
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 23, 2014; first marketed March 24, 1997.
- Drug Identification Number (DIN)
- 02221985
- Company (DIN owner)
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Extended-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Felodipine C08CA02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FELODIPINE | 2.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 4, 2006: NOC 7929New Drug Submission (NDS) · Manufacturer name change
- June 23, 2000: NOC 1164New Drug Submission (NDS)
- June 6, 1996: NOC 4397New Drug Submission (NDS)
Other DINs named RENEDIL
- DIN 02221993 · Cancelled Post Market
- DIN 02222000 · Cancelled Post Market